LI
HAE icon

LRI Investments’s Haemonetics HAE Stock Holding History

LRI Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225 Buy
+3
New +$193 ﹤0.01% 1718
2025
Q4 		– Sell
-54
Closed -$2.64K – 1373
2025
Q3 		$2.64K Hold
54
– – ﹤0.01% 1167
2025
Q2 		$4.04K Hold
54
– – ﹤0.01% 1066
2025
Q1 		$3.44K Hold
54
– – ﹤0.01% 1022
2024
Q4 		$4.23K Hold
54
– – ﹤0.01% 972
2024
Q3 		$4.91K Buy
+54
New +$4.36K ﹤0.01% 940

Other funds holding HAE

RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
IP
Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

LRI Investments's HAE Position: Q2 2026 in Review

LRI Investments opened a new position in Haemonetics (HAE) in Q2 2026: 3 shares worth $225. The stake represents ﹤0.01% of the portfolio and ranks #1718 among its holdings. This is a return to the name: LRI Investments previously reported a position in HAE as recently as Q3 2025.

LRI Investments first reported a position in HAE in Q3 2024 and has held it in 6 quarters since. The position peaked at $4.91K in Q3 2024. 87 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • LRI Investments held 3 shares of Haemonetics worth $225 as of Q2 2026.
  • Haemonetics was a new LRI Investments position in Q2 2026.
  • Haemonetics made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1718 holding.
  • LRI Investments first reported a position in Haemonetics in Q3 2024 and has held it in 6 quarters since.
  • LRI Investments's Haemonetics position peaked at $4.91K in Q3 2024.
  • 87 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.